| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cue Biopharma, Inc.'s insiders have reduced their positions by a net 86,790 shares worth roughly $2.4M. In the past 30 days, 0 insiders bought and 3 sold.
All 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), CUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 694.9K | $19.49M | -11,087 | |
| Other | 116.7K | $3.27M | -1,844 | |
| VP | 47.8K | $1.34M | -1,144 | |
| Dir | 32.6K | - | - | |
| Other | 31.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sell | 1,844 | $28.05 | $51,724.20 | -1.6% | - | - | |
| Oct 12, 2026 | Lin Shao-Lee | Chief Executive Officer | Sell | 11,087 | $27.55 | $305,490.35 | -1.6% | - | - | |
| Oct 12, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sell | 1,144 | $28.05 | $32,089.20 | -2.3% | - | - | |
| Aug 13, 2026 | Ray Sumita | Chief Legal Compliance Officer | Sale+OE | 8,829 | $30.09 | $265,627.93 | -6.9% | - | - | |
| Aug 13, 2026 | Meluzio Michael Vincent | VP, Prin. Accounting Officer | Sale+OE | 5,628 | $30.09 | $169,323.52 | -10.3% | - | - | |
| Aug 13, 2026 | Lin Shao-Lee | Chief Executive Officer | Sale+OE | 58,258 | $27.58 | $1,606,562.42 | -7.6% | - | - | |
| Dec 30, 2025 | Sarraf Pasha | Director | Buy | 323,857 | $0.31 | $99,747.26 | New | -25.2% | - | |
| Dec 16, 2024 | Passeri Daniel R | Chief Executive Officer | Buy | 30,000 | $1.03 | $30,900.00 | +22.3% | -6.9% | -59.8% | |
| Aug 25, 2023 | Suri Anish69 | President and CSO | Buy | 4,000 | $2.76 | $11,040.00 | +3.0% | -12.5% | -72.4% | |
| Aug 14, 2023 | Passeri Daniel R | Chief Executive Officer | Buy | 3,000 | $2.86 | $8,580.00 | +2.3% | -22.1% | -79.3% |